focus -WSS

focus

author：comprehensive 2025-08-12 08:26:15 - browse：47618

Exterior photo of North Country HealthCare. -- biotech coverage from STAT — North Country HealthCare

In Kingman, Ariz., a windswept city of 35,000 at the eastern edge of the Mojave desert, data scientists are about as rare as a drenching rain. The local health clinic doesn’t have a stable internet connection, much less the software to support the latest, greatest artificial intelligence.

But the clinic, a federally qualified health center called North Country HealthCare, has plenty of problems AI could help with.

Its patients’ health problems are complicated, and its clinicians are stretched thin. There is no time, or money, to support bureaucratic battles with insurers or keep up with administrative tasks that AI is handling at the richer academic hospitals with better data systems.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

entertainment

WSS

Change Healthcare cyberattack prompts Medicare loan program

First medicine developed to treat MASH expected to be approved soon

RSV shot was 90% effective at preventing hospitalizations in kids

FDA proposes changes to key medical devices approval pathway

Amylyx ALS drug fails large clinical trial

New weight loss drugs vying to be the next Wegovy or Mounjaro

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Hepatitis C has a cure — but many Americans still lack access to it

Food makers tried to stack nutrition panel with preferred experts

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Bright Health sells Medicare Advantage business to Molina

IRA could hurt research into orphan drugs for rare diseases

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel endorses Alnylam’s heart drug — after picking it apart

focus

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

IVF, abortion rights issues kick off Biden’s State of the Union

UnitedHealth quietly bought dozens of outpatient centers

IRA could hurt research into orphan drugs for rare diseases

FDA proposes changes to key medical devices approval pathway

Will the IRA bring competition to the biologics market?

entertainment

knowledge

Wikipedia

hotspot